Forum for Nordic Dermato-Venereology Nr 3, 2018 | Page 28

Eva Rye Rasmussen – Non-histaminergic Angioedema Patients: Identification, Characterization and Treatment (NAPICAT)
List of original publications
I.
I. Rasmussen ER, von Buchwald C, Wadelius M, Prasad SC3, Ka-
maleswaran S, Ajgeiy KK, et al. Assessment of 105 patients with
angiotensin converting enzyme-inhibitor induced angioedema.
Int J Otolaryngol 2017; 2017: 1476402.
II. Rasmussen ER, Hallberg P, Baranova EV, Eriksson N, Karawajczyk M,
Johansson C, et al. Genome-wide association study of angioedema
induced by agents acting on the angiotensin system. Planned to
be submitted July 2018.
90
D issertation
III. Cornwall JEL, Bygum A, Rasmussen ER. ACE-inhibitor related an-
gioedema is not sufficiently reported to the Danish Adverse Drug
Reactions Database. Planned to be submitted June 2018.
IV. Rasmussen ER, Pottegård A, Bygum A, von Buchwald C, Homøe P,
Hallas J. Angiotensin II receptor blockers are safe in patients with
prior angioedema induced by angiotensin converting enzyme
inhibitors – a nationwide registry-based cohort study. Planned to
be submitted July 2018.
Forum for Nord Derm Ven 2018, Vol. 23, No. 3